Sweden-headed electric pulse technology developer ArcAroma AB (previously known as Arc Aroma Pure AB) has announced that it has obtained patent approval in Japan regarding the company's combination application. The technology is applicable in several areas such as water purification, wastewater treatment, biogas efficiency, and ballast water treatment.
According to a statement, the new patent family describes how different biological particles are effectively selected from a flow prior to treatment with the company’s proprietary CEPT platform, which reduces the load in the biostage and increases the efficiency of the associated biological process.
ArcAroma’s patent attorney, AWA, has announced that Japan has now approved and granted a patent for another of the company’s patent applications. The current patent protects the features of the combination treatment that has been successfully used in wastewater treatment.
By adding a substance to the water flow, biological material can easily be filtered out and thus the dry matter can be increased prior to treatment with CEPT. In this way, the CEPT treatment process can be directed to the fraction in the flow with the highest content of digestible biological particles. The result is higher energy efficiency as the treatment is focused on the digestible solid fraction, which also increases the yield of biogas.
Timely approval
The company says that the new patent is “very welcome” as ArcAroma has recently increased its presence in the region. At the same time, the new patent represents an important milestone in ArcAroma’s patent strategy. ArcAroma has broad patents that describe the introduction of technology in the process industry together with the central solutions that have enabled the development of an extremely energy-efficient CEPT generator.
These patents are gradually supplemented by narrower applications that focus on important central components or methods. ArcAroma has a strategy to apply for patents in countries where there is a market, competitors or potential partners.
It is very gratifying that we have now received another national patent. In this patent, we combine different methods and get a result in accordance with the 1 + 1 = 3 principle. We use a substance that is manufactured on a relatively large scale but which now gets another new interesting application. There are ongoing discussions with an international player that manufactures and markets this particular substance globally. Now we look forward to the results of the industrial evaluations of dynaCEPT at Aarhus Vand’s Egå WWTP in Denmark and VA Syd’s Källby WWTP in Sweden, and then with joint activities to spread the technology in a wider use for, for example, treatment plants where profits are large and where capacity increase without new volumes creates large opportunities in growing metropolitan areas, said Johan Möllerström, CEO, ArcAroma AB.
